Hope for Alzheimer’s patients? Dipeptide blocks the formation of toxic amyloid β-peptide aggregates in mice

Hope for Alzheimer’s patients? Dipeptide blocks the formation of toxic amyloid β-peptide aggregates in mice

(PhysOrg.com) -- Alzheimer's disease is the primary cause of age-related dementia. About 15 million people are affected by this neurodegenerative disease worldwide. It has so far not been possible to combat the causes of Alzheimer’s disease. Israeli researchers have now developed a novel approach for treatment. As they report in the journal Angewandte Chemie, the new drug, a molecule made from two nonphysiological amino acids, improves the cognitive abilities of mice with Alzheimer’s and reduces the amyloid plaques in their brains.

If you want to include this story in your blog, copy and paste this formatted text:

<a href="http://www.physorg.com/news147616157.html">Hope for Alzheimer’s patients? Dipeptide blocks the formation of toxic amyloid β-peptide aggregates in mice</a> (PhysOrg.com) -- Alzheimer's disease is the primary cause of age-related dementia. About 15 million people are affected by this neurodegenerative disease worldwide. It has so far not been possible to combat the causes of Alzheimer’s disease. Israeli researchers have now developed a novel approach for treatment. As they report in the journal Angewandte Chemie, the new drug, a molecule made from two nonphysiological amino acids, improves the cognitive abilities of mice with Alzheimer’s and reduces the amyloid plaques in their brains.